SM_181b: Pituitary/Adrenal/Thyroid Pharmacology Flashcards
Describe basic progression of hypothalamic signaling
Basic progression of hypothalamic signaling
Vasopressin (ADH) is a ____ hormone made in the ____
Vasopressin (ADH) is a peptide hormone made in the posterior pituitary
Vasopressin is secreted in response to ____ or ____ and functions to ____ and ____
Vasopressin is secreted in response to decreased blood pressure and hypertonicity and functions to raise blood pressure and promote water reabsorption
(fluid homeostasis)
Desmopressin is a ____ of vasopressin
Desmopressin is a synthetic long-acting analog of vasopressin
(1-desamino-8-D-arginine vasopressin)
Vasopressin and analogs act through ____
Vasopressin and analogs act through GPCRs
Vasopressin action on V1 receptor involves ____
Vasopressin action on V1 receptor involves coupling to Gq and PLC
- PLC converts PIP2 to DAG and IP3
- Vascular effects: IP3 -> Ca release -> vasoconstriction
- CNS effects: bonding, depression
Vasopressin action on V2 receptor involve ____
Vasopressin action on V2 receptor involve coupling to Gs / adenylate cyclase to increase cAMP and PKA
- Increases water reabsorption from collecting duct through insertion and stabilization of aquaporin-containing vesicles
- Increases factor VIII and VWF
Desmopressin has much ____ antidiuretic / pressor activity than vasopressin and acts preferentially on ____ receptor
Desmopressin has much more antidiuretic / pressor activity than vasopressin and acts preferentially on V2 receptor
Vasopressin is used in treatment of ___
Vasopressin is used in treatment of central diabetes insipidus
- Caused by inadequate secretion of endogenous vasopressin
(also used to stop bleeding from esophageal varices, desmopressin used to stop bleeding in Hemophilia A and von Willebrand’s disease)
Nephrogenic diabetes insipidus is ____
Nephrogenic diabetes insipidus is impaired renal response to vasopressin
- Congenital or drug-induced (lithium)
Nephrogenic diabetes insipidus is treated with ___
Nephrogenic diabetes insipidus is treated with thiazide diuretics
SIADH is treated with ____ such as ____ and ____
SIADH is treated with vasopressin receptor antagonists such as conivaptan and tolvaptan
- Tolvaptan is more selective for V2 receptors and is orally effective but can be hepatotoxic
- Etiology of SIADH: malignancy, head injuries, drugs (psychotropics, sulfonylureas, vinca alkaloids)
Oxytocin is similar in structure to ____
Oxytocin is similar in structure to oxytocin
(9 amino acid peptides)
Oxytocin activates ____
Oxytocin activates GPCRs on smooth muscle for contraction
- Gq -> PLC -> Ca -> calmodulin -> myosin
- Promotes release of prostaglandins and leukotrienes
Oxytocin is used to ____ and ____
Oxytocin is used to induce labor under restricted conditions and control postpartum uterine hemorrhage
- Induce labor under restricted conditions: when early vaginal delivery is complicated (eclampsia), when labor is protracted or arrested
- Hepatic and renal metabolism
Growth hormone is a ____ produced in the ____
Growth hormone is a 191-amino acid peptide produces in somatotropes of the anterior pituitary
Growth hormone is positively regulated by ____ and negatively regulated by ____ and ____
Growth hormone is positively regulated by GHRH and negatively regulated by somatostatin and dopamine
Describe the action of growth hormone
Growth hormone action
- Stimulates longitudinal growth of bone until epiphyseal closure
- Increases muscle mass
- Decreases central adiposity
- Reduces sensitivity to insluin
GH deficiency during childhood / adolescence results in ____, ____, and ____
GH deficiency during childhood / adolescence results in short stature, decreases muscle mass, and increased body fat
GH acts through homodimeric ____ membrane receptors
GH acts through homodimeric tyrosine-kinase linked membrane receptors (JAK)
- JAK causes activation of STAT proteins and subsequent downstream effects
Most of the actions of GH are mediated through hepatic production of ____
Most of the actions of GH are mediated through hepatic production of insulin-like growth factor-I (IGF-I)
- IGF-I synthesis can also be stimulated by other agents
- IGF-I and GH can downregulate GH secretion
____ and ____ are GH agonists
Somatropin and somatrem are GH agonists
- Somatropin: recombinant peptide that is identical to native human GH
- Somatrem: has additional methionine, prolonging half life
Describe uses of GH
GH uses
- Replacement in children with GH
- Other causes of short stature (Turner, Prader-Willi, chronic renal insufficiency, idiopathic short stature)
- Used for AIDS wasting, malabsorption
- Abused as anti-aging remedy
- Illegally used in sports
____ and ____ are IGF-1 agonists
Mecasermin and mecasermin rinfabate are IGF-1 agonists
- Mecasermin: recombinant form of IGF-1
- Mecasermin rinfabate: contains IGF-1 and IGF-1 binding protein IGFBP-3, which prolongs half life
IGF-1 agonists are used to ____
IGF-1 agonists are used to promote growth and normalize metabolism in IGF-1 deficiency resistant to GH
(mecasermin, mecasermin rinfabate)
Acromegally results in ____ leading to ____
Acromegally results in GH excess leading to abnormal growth of bone and cartilage
____, ____, and ____ are drug treatments for GH excess
Somatostatin analog octreotide, GH receptor antagonist pegvisomant, and dopaminergic agonists are drug treatments for GH excess
Octreotide is ____ than somatostatin in inhibiting GH secretion
Octreotide is more potent than somatostatin in inhibiting GH secretion
Otreotide acts through ____ receptors to activate ____ and ____
Otreotide acts through somatostatin receptors receptors to activate K channels and protein phosphotyrosine phosphotases
- Somatostatin receptors: family of GPCRs that couple through Gi
Octreotide acts to ____
Octreotide acts to inhibit GH secretion
- Also inhibits secretion of TSH, ACTH, glucagon, gastrin, insulin
Octreotide is used for ____, ____, ____, and ____
Octreotide is used for acromegaly, other hormone-secreting tumors, secretory diarrhea from chemotherapy, and dumping syndrome after gastric surgery
____ is a long acting analog of octreotide
Lanreotide is a long acting analog of octreotide
(somatostatin analog -> GH antagonist)
Pegvisomant is a ____ that is a ____
Pegvisomant is a modified mutant form of growth hormone that is a GH receptor antagonist
Pegvisomant functions to ____
Pegvisomant functions to allow receptor dimerization but blocks subsequent signaling, preventing activation of JAK-STAT and secretion of IGF-1
(GH receptor antagonist)
Pegvisomant is used to treat ____
Pegvisomant is used to treat acromegaly
____ and ____ are D2 agonists
Bromocriptine and cabergoline are D2 agonists
- GH antagonists
- Semisynthetic ergot alkaloids
Describe the mechanism of bromocriptine and cabergoline
Bromocriptine and cabergoline mechanism
- Selective dopamine D2 receptor agonists
- Mimic effects of dopamine to inhibit GH production and secretion
- Even more effective in inhibiting prolactin